Skip to content

Effects of single bolus dose of morphine versus dexmedetomidine infusion on quality of extubation.

Effects of single bolus dose of morphine versus dexmedetomidine infusion on quality of extubation: A prospective, randomized, double-blind study. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066133
Enrollment
116
Registered
2024-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: A single bolus dose of 0.1mg/kg morphine: Following induction and intubation,Patients will receive a single bolus dose of 0.1mg/kg morphine diluted to 10ml with normal saline. Control

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients aged 18-65 years. 2) Patients coming under American Society of Anesthesiologists physical status28 I and II (Annexure IV). 3) Patients undergoing elective surgical procedures of expected duration of less than 4- hour requiring general anesthesia with endotracheal intubation.

Exclusion criteria

Exclusion criteria: 1)Patient refusal to give informed consent. 2)Patients with body mass index (BMI) > 30 kg/m2. 3)Patients with history of respiratory, cardiac, hepatic, renal and neuromuscular disorders. 4)Patients with chronic alcohol or drug abuse. 5)Patients being treated with rate controlling drugs, anticonvulsants or psychotropic medications. 6)Patients undergoing oro-naso pharyngolaryngeal surgeries. 7)Patients with anticipated difficult intubation. 8)Surgeries with expected duration more than 4 hours will be excluded. 9)Patients with history of allergy to the study drugs. 10)Pregnant or lactating mother.

Design outcomes

Primary

MeasureTime frame
To assess the quality of extubation according to the 5-point extubation score.Timepoint: assessing the quality of extubation according to the 5-point extubation score at the time of extubation.

Secondary

MeasureTime frame
To assess Residual sedation.Timepoint: At the time of arrival in the post anesthesia care unit.;To assess Adverse cardiovascular effects (bradycardia, hypotension, tachycardia, hypertension, arrhythmias) in the peri-extubation period.Timepoint: The time interval from discontinuation of anesthetic agents to 15min after extubation.;To assess Level of agitation during emergence using Ricker sedation-agitation scale.Timepoint: assessing Level of agitation during emergence after tracheal extubation.;To assess Other complications (desaturation, laryngospasm, bronchospasm) in the post extubation period.Timepoint: The time interval from tracheal extubation to 15min after extubation.;To assess Pain score at arrival in the post anesthesia care unit (PACU).Timepoint: Pain score at the time of arrival in the post anesthesia care unit.;To assess Time to extubation. Timepoint: The time interval from discontinuation of anesthetic agents to tracheal extubation.

Countries

India

Contacts

Public ContactDr R Sri Devi

Sri Venkateswara Institute of Medical Sciences

sridevi.radhapuram@gmail.com9493547661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026